Brains to provide EU-GMP CBD API for Brazils first medical approved cannabis product

Brains Bioceutical Corp, a global leader in pharmaceutical, wellness and veterinary cannabidiol (CBD) based Active Pharmaceutical Ingredient (API) production, is proud to announce its landmark…

Brains Bioceutical Corp, a global leader in pharmaceutical, wellness and veterinary cannabidiol (CBD) based Active Pharmaceutical Ingredient (API) production, is proud to announce its landmark accomplishment to bring Brazil’s first registered medical cannabis product under the new regulations that ANVISA put in place in December of 2019, Brains EU-GMP CBD API to the Brazilian market. […]

The post Brains to provide EU-GMP CBD API for Brazils first medical approved cannabis product appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *